Sun Pharma
Business

Sun Pharma Launches Palbociclib, A Novel Targeted Therapy For Advanced Breast Cancer With A Unique Patient Assistance Program

Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies Sun Pharma’s brand, PALENOTM is the branded generic version of the innovator product Sun Pharmaceutical Industries Limited today announced that one of its wholly-owned subsidiaries has launched a novel anti-cancer drug, Palbociclib in India for patients who have advanced […]